Shenzhen YHLO Biotech Past Earnings Performance
Past criteria checks 2/6
Shenzhen YHLO Biotech has been growing earnings at an average annual rate of 13.9%, while the Medical Equipment industry saw earnings growing at 6.1% annually. Revenues have been growing at an average rate of 16.8% per year. Shenzhen YHLO Biotech's return on equity is 8.8%, and it has net margins of 15.2%.
Key information
13.9%
Earnings growth rate
14.0%
EPS growth rate
| Medical Equipment Industry Growth | 16.0% |
| Revenue growth rate | 16.8% |
| Return on equity | 8.8% |
| Net Margin | 15.2% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
We Think That There Are More Issues For Shenzhen YHLO Biotech (SHSE:688575) Than Just Sluggish Earnings
Nov 06
Shenzhen YHLO Biotech's (SHSE:688575) Sluggish Earnings Might Be Just The Beginning Of Its Problems
May 01Recent updates
Shenzhen YHLO Biotech (SHSE:688575) Has A Pretty Healthy Balance Sheet
Nov 27We Think That There Are More Issues For Shenzhen YHLO Biotech (SHSE:688575) Than Just Sluggish Earnings
Nov 06Slammed 25% Shenzhen YHLO Biotech Co., Ltd. (SHSE:688575) Screens Well Here But There Might Be A Catch
Nov 04Estimating The Intrinsic Value Of Shenzhen YHLO Biotech Co., Ltd. (SHSE:688575)
Oct 31Shenzhen YHLO Biotech (SHSE:688575) Is Reinvesting At Lower Rates Of Return
Oct 12Shenzhen YHLO Biotech Co., Ltd.'s (SHSE:688575) Price In Tune With Earnings
Aug 30Does Shenzhen YHLO Biotech (SHSE:688575) Have A Healthy Balance Sheet?
Jul 18Shenzhen YHLO Biotech Co., Ltd. (SHSE:688575) Not Lagging Market On Growth Or Pricing
May 23Shenzhen YHLO Biotech's (SHSE:688575) Sluggish Earnings Might Be Just The Beginning Of Its Problems
May 01There Are Reasons To Feel Uneasy About Shenzhen YHLO Biotech's (SHSE:688575) Returns On Capital
Mar 19Revenue & Expenses Breakdown
How Shenzhen YHLO Biotech makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 1,902 | 289 | 592 | 329 |
| 30 Jun 24 | 1,938 | 387 | 591 | 330 |
| 31 Mar 24 | 1,824 | 340 | 569 | 338 |
| 31 Dec 23 | 2,053 | 355 | 573 | 314 |
| 30 Sep 23 | 2,397 | 424 | 466 | 275 |
| 30 Jun 23 | 2,719 | 488 | 451 | 247 |
| 31 Mar 23 | 3,271 | 582 | 548 | 243 |
| 31 Dec 22 | 3,981 | 1,012 | 629 | 238 |
| 30 Sep 22 | 3,450 | 923 | 667 | 208 |
| 30 Jun 22 | 2,967 | 782 | 606 | 193 |
| 31 Mar 22 | 2,312 | 678 | 463 | 154 |
| 31 Dec 21 | 1,178 | 205 | 299 | 129 |
| 30 Sep 21 | 1,147 | 216 | 269 | 128 |
| 30 Jun 21 | 1,118 | 198 | 252 | 126 |
| 31 Mar 21 | 1,020 | 198 | 228 | 111 |
| 01 Jan 21 | 999 | 211 | 220 | 102 |
| 31 Dec 19 | 877 | 108 | 223 | 80 |
| 31 Dec 18 | 729 | 38 | 180 | 51 |
Quality Earnings: 688575 has high quality earnings.
Growing Profit Margin: 688575's current net profit margins (15.2%) are lower than last year (17.7%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 688575's earnings have grown by 13.9% per year over the past 5 years.
Accelerating Growth: 688575's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: 688575 had negative earnings growth (-31.9%) over the past year, making it difficult to compare to the Medical Equipment industry average (-8.8%).
Return on Equity
High ROE: 688575's Return on Equity (8.8%) is considered low.